Dementia is not a single disease. It’s an umbrella term for a range of conditions that cause declining memory, thinking, and the ability to perform everyday tasks. Alzheimer’s disease is one specific type of dementia, and it’s the most common, accounting for 60% to 80% of all dementia cases. So every person with Alzheimer’s has dementia, but not every person with dementia has Alzheimer’s.
This distinction matters because different types of dementia have different causes, different early warning signs, and in some cases, different treatment options. Understanding which type of dementia someone has can shape what to expect and how to respond.
Dementia as a Category, Alzheimer’s as a Cause
Think of it like chest pain. Chest pain is a symptom that can come from many sources: a heart attack, acid reflux, a pulled muscle, anxiety. Similarly, dementia describes a set of symptoms, primarily memory loss, confusion, and difficulty with reasoning, that can stem from several distinct brain diseases. Alzheimer’s is the most frequent cause, but vascular dementia, Lewy body dementia, and frontotemporal dementia are other well-known types, each with its own pattern of brain damage.
Worldwide, roughly 57 million people were living with some form of dementia as of 2021, with nearly 10 million new cases each year. The sheer scale of these numbers reflects the full range of conditions under the dementia umbrella, not just Alzheimer’s alone.
What Happens in the Brain With Alzheimer’s
Alzheimer’s disease has two signature features in the brain: sticky protein clumps called amyloid plaques and twisted fibers called tau tangles. These abnormal proteins disrupt communication between brain cells and eventually kill them. What makes Alzheimer’s particularly difficult to catch early is that these changes begin long before symptoms appear. Amyloid buildup can start roughly two decades before noticeable memory problems, and tau tangles show up in memory-related brain regions about six years before mild cognitive impairment begins.
Other types of dementia damage the brain differently. Vascular dementia results from reduced blood flow to the brain, often after strokes or chronic blood vessel disease. Lewy body dementia involves abnormal protein deposits (different from amyloid) that form inside nerve cells and affect both movement and cognition. Frontotemporal dementia targets the front and side regions of the brain, hitting personality and language before memory.
How Symptoms Differ by Type
Alzheimer’s typically starts with memory problems. In the mild stage, people repeat questions, get lost in familiar places, and struggle to recall recent conversations. As it progresses to the moderate stage, they may not recognize friends or family and may act impulsively. In the severe stage, communication breaks down almost entirely.
Lewy body dementia looks quite different early on. Instead of pure memory loss, it tends to cause trouble with focus and alertness, visual hallucinations, sleep disruptions like insomnia or excessive daytime sleepiness, and movement problems such as muscle rigidity and reduced facial expression. Someone with Lewy body dementia might seem fine one hour and deeply confused the next, with fluctuations that can catch caregivers off guard.
Frontotemporal dementia often hits personality first. A person may become impulsive, emotionally flat, or struggle to plan and organize. Language problems, including difficulty producing or understanding speech, are common. Memory may stay relatively intact early on, which is why it’s sometimes misdiagnosed as a psychiatric condition rather than a neurological one.
Vascular dementia symptoms depend on where in the brain blood flow has been disrupted. Forgetting events, misplacing items, and difficulty following instructions are typical. Poor judgment, hallucinations, and trouble learning new information can also appear. Unlike Alzheimer’s gradual slide, vascular dementia sometimes worsens in sudden steps, particularly after a new stroke.
How Doctors Tell Them Apart
Diagnosing the specific type of dementia involves several layers of testing. A neurological exam checks reflexes, coordination, muscle tone, eye movement, and speech, looking for signs of stroke, Parkinson’s disease, tumors, or fluid buildup in the brain. Cognitive and behavioral tests evaluate memory, problem-solving, and changes in daily functioning.
Blood and urine tests play an important role in ruling out conditions that can mimic dementia. Depression, untreated sleep apnea, thyroid problems, vitamin deficiencies, medication side effects, and excessive alcohol use can all cause memory and thinking problems that look like dementia but are potentially reversible. Researchers at the University of Wisconsin found that about 40% of new patients presenting with memory complaints at their clinic were deficient in at least one key vitamin, including B1, B6, B12, folate, or vitamin D. If those deficiencies go uncorrected, even effective treatments for the underlying condition won’t work well.
Brain imaging can reveal structural problems like evidence of strokes or tumors. In some cases, imaging can detect high levels of amyloid protein in the brain. If amyloid levels are normal, Alzheimer’s is likely not the cause. Newer FDA-approved tests can also measure amyloid and tau markers in spinal fluid, helping confirm or rule out Alzheimer’s specifically.
How Alzheimer’s Progresses Over Time
Alzheimer’s generally moves through five stages: a preclinical phase with no noticeable symptoms, mild cognitive impairment, then mild, moderate, and severe dementia. The preclinical stage can last years or even decades, with brain changes silently accumulating while the person functions normally. Mild cognitive impairment brings memory lapses, like forgetting appointments or recent conversations, but not enough to disrupt work or relationships. Once it reaches the mild dementia stage, the impact on daily life becomes clear to family and doctors, and this is when Alzheimer’s is most often diagnosed.
The rate of decline varies widely. On average, people live between three and 11 years after diagnosis, though some live 20 years or more. How far the disease has progressed at the time of diagnosis affects life expectancy, and untreated vascular risk factors like high blood pressure can accelerate the decline.
Treatment Options
Because Alzheimer’s has a specific biological mechanism, it has disease-specific treatments that don’t apply to other dementias. The FDA has approved medications that target amyloid plaques in the brain, aiming to slow the disease rather than just manage symptoms. These treatments are designed for people in the early stages, with mild cognitive impairment or mild dementia. They’re given as infusions every four weeks and have been shown to reduce the rate of cognitive and functional decline compared to placebo.
These newer treatments carry real risks. The most notable is temporary brain swelling, sometimes accompanied by small spots of bleeding, which usually resolves over time but requires monitoring with brain scans. People with certain genetic profiles have a higher chance of this side effect, so genetic testing is recommended before starting treatment.
For other types of dementia, treatment focuses primarily on managing symptoms and addressing underlying causes where possible. Vascular dementia management centers on controlling blood pressure, cholesterol, and other cardiovascular risk factors to prevent further brain damage. Lewy body dementia requires careful medication choices because some drugs used for other conditions can worsen its symptoms. Frontotemporal dementia currently has no disease-modifying treatments, with care focused on behavioral management and speech therapy.
Across all types of dementia, non-drug approaches matter: physical activity, social engagement, structured routines, and caregiver support all play a role in maintaining quality of life as the condition progresses.